Tag: tumour ablation
Histotripsy: Less invasive does not equal less risk
For histotripsy, as with every disruptive medical technology, the transition from carefully controlled clinical trials to clinical practice has inevitably revealed adverse events that...
AngioDynamics expands European indications for NanoKnife system
AngioDynamics has expanded indications across Europe for its NanoKnife system to include soft tissue ablation for tumours in the liver, kidney, prostate and pancreas,...
CIRSE launch immuno-oncology trial alongside Immunophotonics
Immunophotonics has announced a collaboration with The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) around a phase 2/3 clinical trial.
The trial is designed...
